Conducting randomized controlled trials in acute care settings presents significant logistical and clinical challenges. Specifically, a recent cluster-randomised cross-over trial comparing cephalosporin monotherapy to combination therapy for sepsis was terminated prematurely. This study ended due to operational futility, primarily stemming from sepsis trial enrollment barriers and low protocol adherence. Consequently, this failure highlights the necessity of understanding why clinicians and patients struggle to participate in such critical research.

Primary Sepsis Trial Enrollment Barriers

For this reason, researchers used questionnaires and screening logs to evaluate why the trial failed to meet its targets. As a result, findings showed that 52.2% of screened patients were excluded because they met at least one exclusion criterion. Additionally, over 15.6% of eligible patients declined to provide consent for participation. Therefore, the higher-than-expected exclusion rate became the most significant hurdle for the local research teams. Furthermore, staff reported that the complexity of screening inclusion and exclusion criteria made real-time enrolment difficult in a fast-paced emergency environment.

Treatment Compliance and Staff Perceptions

In addition to recruitment issues, protocol adherence varied significantly between treatment arms. Specifically, clinicians expressed substantial concerns regarding the potential side effects of combination therapy, particularly involving short-course aminoglycosides. Moreover, many supervisors recommended deviating from the study protocol based on their individual clinical judgment. Interestingly, while research teams felt that ongoing training was a major barrier for implementation, bedside clinical staff viewed it as a low-priority issue. In contrast, monotherapy adherence faced no significant obstacles, likely due to its perceived safety and simplicity for sepsis management.

Improving Future Acute Care Trials

To address these issues, the study authors conclude that pilot studies are essential before launching large-scale trials. Specifically, both quantitative and qualitative pilot phases can identify potential sepsis trial enrollment barriers early in the design process. In doing so, researchers can optimize recruitment strategies and address clinician safety concerns to improve protocol adherence. Finally, keeping clinical staff engaged and well-informed remains vital for the successful implementation of complex antibiotic regimens in acute care.

Frequently Asked Questions

Why was the sepsis antibiotic trial terminated?

The trial was terminated for operational futility because it failed to reach enrolment targets and suffered from poor protocol adherence among clinical staff due to concerns about side effects.

What were the main reasons for patient exclusion?

More than half of the patients screened were excluded due to specific exclusion criteria, and a significant portion of eligible individuals declined to participate in the study entirely.

How can researchers improve future antibiotic trials?

Experts recommend conducting pilot studies to identify barriers during the design phase and simplifying protocols to reduce clinician concerns regarding drug toxicity and side effects.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional recommendation. Clinical decisions should be made based on individual patient needs and the expertise of the treating physician. Refer to the latest local and national guidelines for clinical practice.

References

van den Eijnde SEJD et al. Failure to rescue the trial: lessons from a randomised antibiotic treatment trial in the acute care setting. Trials. 2026 Apr 23. doi: 10.1186/s13063-026-09722-3. PMID: 42026686.

Miseta E. The (Almost) Insurmountable Recruitment Challenges of Antibiotic Clinical Trials. Clinical Leader. May 2020. Available at: https://www.clinicalleader.com/doc/the-almost-insurmountable-recruitment-challenges-of-antibiotic-clinical-trials-0001

Lamba V, et al. Barriers and facilitators to optimal sepsis care – a systematized review of healthcare professionals' perspectives. NIH PubMed. April 2025. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11041641/